CareDx, Inc (CDNA) vs Regencell Bioscience Holdings Limited (RGC)

A side-by-side comparison of CareDx, Inc and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDNA vs RGC

growth of $100 · dividends reinvested · last 5y
CDNA -11.6% (-2.4%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
1101001k10k100kStart $10020222023202420252026$88$2,620
CDNA RGC

CDNA vs RGC: by the numbers

  • •RGC is the larger company ($3.64B vs $3.30B market cap).
  • •CDNA is profitable (24.23% net margin) while RGC runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCDNARGC
P/E ratio30.80N/A
Forward P/E53.26N/A
P/S ratio7.20N/A
P/B ratio7.752986.54
EV / EBITDA189.34N/A
FCF yield2.58%N/A

Profitability

MetricCDNARGC
Gross margin70.58%0.00%
Operating margin-0.92%0.00%
Net margin24.23%0.00%
ROE26.08%-73.75%
ROIC-0.93%-69.75%

Growth (annualized)

MetricCDNARGC
Revenue CAGR (5Y)12.56%N/A
Total return CAGR (5Y)1.33%67.94%

Frequently asked

Is CDNA or RGC more profitable?
CDNA runs the higher net margin — CDNA at 24.23% versus RGC at 0.00%.
How have CDNA and RGC total returns compared?
Over the past 5 years, CDNA delivered 1.33% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.